The FDA has called for a pause in the use of the Johnson & Johnson Covid-19 vaccine after reports of severe blood clotting.
There have been six cases of severe blood clotting in 6.8 million doses of the vaccine. This comes after similar reports of blood clots with the AstraZeneca vaccine.
The FDA and the CDC have said they were reviewing the six cases of blood clots and recommending a pause out of “an abundance of caution”. Johnson & Johnson has said the following:
We are aware that thromboembolic events including those with thrombocytopenia have been reported with Covid-19 vaccines. At present, no clear causal relationship has been established between these rare events and the Janssen (J&J) Covid-19 vaccine.
Covid-19: US agencies call for pause in Johnson & Johnson vaccine
At OLM we recommend prioritizing a healthy diet and lifestyle for coronavirus prevention.